A major prospective, multicenter study titled DETECT – HCC CSPH Sarcopenia is launching to improve surveillance and prognosis in liver cirrhosis patients. The study will involve 600 participants and aims to compare the effectiveness of abbreviated MRI versus ultrasound in detecting hepatocellular carcinoma (HCC).
Additionally, the study will investigate the relevance of muscle health (sarcopenia) in patient prognosis and its relationship with clinically significant portal hypertension (CSPH). The findings could lead to improved surveillance methods and better patient outcomes in cirrhosis management.
For more information, please contact the Prospective Cirrhosis Study: DETECT – HCC CSPH Sarcopenia team at Linköping University via email at: mattias.ekstedt@liu.se